Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 22;9(10):1441.
doi: 10.3390/children9101441.

Rhabdomyolysis in Pediatric Patients with SARS-CoV-2 Infection

Affiliations

Rhabdomyolysis in Pediatric Patients with SARS-CoV-2 Infection

Ping-Sheng Wu et al. Children (Basel). .

Abstract

Background: Rhabdomyolysis is a rare but severe complication in adult patients with Coronavirus disease 2019 (COVID-19), which can result in acute kidney injury and death; however, it is rarely reported in pediatric patients.

Methods: In this study, we retrospectively reviewed the clinical features and outcomes of rhabdomyolysis in pediatric patients aged 0-18 years with COVID-19 who were hospitalized at Taipei Tzu Chi Hospital, an epicenter of COVID-19 in northern Taiwan.

Results: We treated eight patients with rhabdomyolysis during the omicron variant-Severe acute respiratory syndrome coronavirus 2 (omicron variant-SARS-CoV-2) community outbreak and none during the alpha variant endemic. These eight patients shared stereotypical presentations, including the presence of bilateral calf pain after defervescence. The creatinine kinase (CK) levels were between 1346 and 6937 U/L on admission, and clinical course was uneventful after aggressive saline hydration.

Conclusion: Rhabdomyolysis is not a rare complication in pediatric patients with the omicron-SARS-CoV-2 infection, and reassurance of a good prognosis is important to alleviate family anxiety.

Keywords: COVID-19; child; hospital care; rhabdomyolysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Changes in creatinine kinase (CK) in eight patients with rhabdomyolysis after COVID-19 symptoms began. The trends of individuals’ CK level were shown by the solid lines.

Similar articles

Cited by

References

    1. Buckholz A.P., Kaplan A., Rosenblatt R.E., Wan D. Clinical Characteristics, Diagnosis, and Outcomes of 6 Patients with COVID-19 Infection and Rhabdomyolysis. Mayo Clin. Proc. 2020;95:2557–2559. doi: 10.1016/j.mayocp.2020.09.005. - DOI - PMC - PubMed
    1. Jin M., Tong Q. Rhabdomyolysis as Potential Late Complication Associated with COVID-19. Emerg. Infect. Dis. 2020;26:1618–1620. doi: 10.3201/eid2607.200445. - DOI - PMC - PubMed
    1. Khosla S.G., Nylen E.S., Khosla R. Rhabdomyolysis in Patients Hospitalized With COVID-19 Infection: Five Case Series. J. Investig. Med. High Impact. Case Rep. 2020;8:2324709620984603. doi: 10.1177/2324709620984603. - DOI - PMC - PubMed
    1. Meegada S., Muppidi V., Wilkinson D.C., 3rd, Siddamreddy S., Katta S.K. Coronavirus Disease 2019-Induced Rhabdomyolysis. Cureus. 2020;12:e10123. doi: 10.7759/cureus.10123. - DOI - PMC - PubMed
    1. Rivas-García S., Bernal J., Bachiller-Corral J. Rhabdomyolysis as the main manifestation of coronavirus disease 2019. Rheumatology. 2020;59:2174–2176. doi: 10.1093/rheumatology/keaa351. - DOI - PMC - PubMed